Total Payments
$983.41
2024 Payments
$86.70
Companies
9
Transactions
47
Medicare Patients
3,197
Medicare Billing
$385,872
Payment Breakdown by Category
Food & Beverage$824.03 (83.8%)
Gifts$159.38 (16.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $824.03 | 45 | 83.8% |
| Gift | $159.38 | 2 | 16.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $336.00 | 24 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $166.64 | 7 | $0 (2024) |
| Braintree Laboratories, Inc. | $159.38 | 2 | $0 (2023) |
| Boston Scientific Corporation | $140.65 | 4 | $0 (2019) |
| Covidien LP | $58.35 | 3 | $0 (2017) |
| Apollo Endosurgery US Inc | $43.38 | 3 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $32.10 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $27.14 | 2 | $0 (2022) |
| Celgene Corporation | $19.77 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.70 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($54.60) |
| 2023 | $285.84 | 14 | AbbVie Inc. ($129.71) |
| 2022 | $337.08 | 18 | ABBVIE INC. ($195.58) |
| 2019 | $94.63 | 4 | Boston Scientific Corporation ($51.25) |
| 2018 | $74.66 | 2 | BOSTON SCIENTIFIC CORPORATION ($53.96) |
| 2017 | $104.50 | 6 | Covidien LP ($58.35) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/08/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2023 | AbbVie Inc. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: IMMUNOLOGY | ||||||
| 05/05/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Gift | Cash or cash equivalent | $79.69 | General |
| Category: GI COLON PREP | ||||||
| 04/13/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| Category: Neuroscience | ||||||
| 04/10/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/28/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2023 | AbbVie Inc. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: IMMUNOLOGY | ||||||
| 01/10/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Immunology | ||||||
| 08/09/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 735 | 767 | $880,175 | $80,946 |
| 2022 | 16 | 668 | 700 | $672,270 | $81,542 |
| 2021 | 17 | 901 | 946 | $592,443 | $110,394 |
| 2020 | 18 | 893 | 938 | $657,703 | $112,989 |
Total Patients
3,197
Total Services
3,351
Medicare Billing
$385,872
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 110 | 110 | $296,040 | $22,625 | 7.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 108 | 108 | $47,636 | $13,351 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 95 | 95 | $26,981 | $7,908 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 55 | $16,880 | $5,419 | 32.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 98 | 101 | $158,927 | $5,358 | 3.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 49 | 50 | $100,137 | $5,331 | 5.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 71 | $14,694 | $4,684 | 31.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 45 | 48 | $77,408 | $4,077 | 5.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $13,733 | $2,792 | 20.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 13 | 13 | $26,061 | $2,178 | 8.4% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 20 | 20 | $40,580 | $2,157 | 5.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $23,751 | $1,740 | 7.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 20 | $26,315 | $1,690 | 6.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 24 | $3,760 | $945.60 | 25.1% |
| 91010 | Study of esophagus to assess movement | Office | 2023 | 12 | 12 | $7,272 | $690.31 | 9.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 152 | 153 | $264,775 | $30,562 | 11.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 125 | 125 | $49,304 | $15,198 | 30.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 99 | 100 | $124,462 | $6,083 | 4.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 45 | 47 | $40,236 | $4,148 | 10.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 22 | 22 | $26,266 | $3,888 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 41 | $8,587 | $3,208 | 37.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 23 | 24 | $30,576 | $2,973 | 9.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $18,588 | $2,588 | 13.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $7,906 | $2,519 | 31.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $53,023 | $2,438 | 4.6% |
About Dr. William Cobell, MD
Dr. William Cobell, MD is a Gastroenterology healthcare provider based in Anaconda, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1023281441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Cobell, MD has received a total of $983.41 in payments from pharmaceutical and medical device companies, with $86.70 received in 2024. These payments were reported across 47 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($824.03).
As a Medicare-enrolled provider, Cobell has provided services to 3,197 Medicare beneficiaries, totaling 3,351 services with total Medicare billing of $385,872. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Anaconda, MT
- Active Since 04/07/2008
- Last Updated 09/11/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1023281441
Products in Payments
- RINVOQ (Biological) $167.63
- SUTAB (Drug) $159.38
- ENTYVIO (Biological) $145.94
- SKYRIZI (Biological) $135.79
- Barrx (Device) $58.35
- GENERAL BILIARY DEVICES (Device) $53.96
- GENERAL THERAPIES (Device) $51.25
- Orbera (Device) $43.38
- DUPIXENT (Biological) $32.10
- STELARA (Biological) $27.14
- HUMIRA (Biological) $21.87
- Entyvio (Biological) $20.70
- GENERAL - THERAPIES (Device) $19.94
- ZEPOSIA (Drug) $19.77
- RESOLUTION CLIP (Device) $15.50
- Humira (Biological) $10.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.